Cutaneous lupus erythematosus (CLE) is a rare autoimmune disease with a heterogeneous spectrum of clinical manifestations on the skin. Prof. Dr. med. Luca Borradori, Chief Physician and Clinic Director of Dermatology at Inselspital Bern, gave an up-to-date overview of the diagnostic clarifications to be carried out in the event of a clinical suspicion of CLE and the treatment options available. With adequate disease management, many CLE patients can maintain a good quality of life.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Diabetic ketoacidosis
Recommendations for action in practice
- Migraine: better quality of life thanks to multimodal care
Broader selection of innovative migraine prophylactics and acute therapies
- Therapy of non-tumor-related pain
Do not prescribe opioids lightly for musculoskeletal pain
- Migraine
Fremanezumab for comorbid migraine and depression
- Case study
Moyamoya disease in a 23-year-old female patient
- Dapagliflozin for T2D and heart failure
Epicardial fat reduced in patients with type 2 diabetes and HF
- A hub of biological aging
Mitochondrial dysfunction and energy metabolism
- Health Literacy